請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58237完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 張 鑫(Shin C. Chang) | |
| dc.contributor.author | Wei-Chien Ma | en |
| dc.contributor.author | 馬瑋健 | zh_TW |
| dc.date.accessioned | 2021-06-16T08:09:00Z | - |
| dc.date.available | 2019-10-09 | |
| dc.date.copyright | 2014-10-09 | |
| dc.date.issued | 2014 | |
| dc.date.submitted | 2014-05-09 | |
| dc.identifier.citation | Abe, K., Emori, Y., Kondo, H., Arai, S., Suzuki, K., 1988. The NH2-terminal 21 amino acid residues are not essential for the papain-inhibitory activity of oryzacystatin, a member of the cystatin superfamily. Expression of oryzacystatin cDNA and its truncated fragments in Escherichia coli. J Biol Chem 263, 7655-7659.
Appel, N., Pietschmann, T., Bartenschlager, R., 2005. Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain. J Virol 79, 3187-3194. Barrett, A.J., Fritz, H., Grubb, A., Isemura, S., Jarvinen, M., Katunuma, N., Machleidt, W., Muller-Esterl, W., Sasaki, M., Turk, V., 1986. Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochem J 236, 312. Barrett, A.J., Kirschke, H., 1981. Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol 80 Pt C, 535-561. Bartenschlager, R., Lohmann, V., Wilkinson, T., Koch, J.O., 1995. Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J Virol 69, 7519-7528. Beard, M.R., Abell, G., Honda, M., Carroll, A., Gartland, M., Clarke, B., Suzuki, K., Lanford, R., Sangar, D.V., Lemon, S.M., 1999. An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology 30, 316-324. Bjorck, L., Grubb, A., Kjellen, L., 1990. Cystatin C, a human proteinase inhibitor, blocks replication of herpes simplex virus. J Virol 64, 941-943. Bobek, L.A., Levine, M.J., 1992. Cystatins--inhibitors of cysteine proteinases. Crit Rev Oral Biol Med 3, 307-332. Bode, W., Engh, R., Musil, D., Thiele, U., Huber, R., Karshikov, A., Brzin, J., Kos, J., Turk, V., 1988. The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J 7, 2593-2599. Bonkovsky, H.L., Mehta, S., 2001. Hepatitis C: a review and update. J Am Acad Dermatol 44, 159-182. Chang, S.C., Yen, J.H., Kang, H.Y., Jang, M.H., Chang, M.F., 1994. Nuclear localization signals in the core protein of hepatitis C virus. Biochem Biophys Res Commun 205, 1284-1290. Choo, Q.L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W., Houghton, M., 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362. Choo, Q.L., Richman, K.H., Han, J.H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, R., Barr, P.J., et al., 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 88, 2451-2455. Cocquerel, L., Meunier, J.C., Pillez, A., Wychowski, C., Dubuisson, J., 1998. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J Virol 72, 2183-2191. Deleersnyder, V., Pillez, A., Wychowski, C., Blight, K., Xu, J., Hahn, Y.S., Rice, C.M., Dubuisson, J., 1997. Formation of native hepatitis C virus glycoprotein complexes. J Virol 71, 697-704. Erdtmann, L., Franck, N., Lerat, H., Le Seyec, J., Gilot, D., Cannie, I., Gripon, P., Hibner, U., Guguen-Guillouzo, C., 2003. The hepatitis C virus NS2 protein is an inhibitor of CIDE-B-induced apoptosis. J Biol Chem 278, 18256-18264. Fossum, K., Whitaker, J.R., 1968. Ficin and papain inhibitor from chicken egg white. Arch Biochem Biophys 125, 367-375. Franck, N., Le Seyec, J., Guguen-Guillouzo, C., Erdtmann, L., 2005. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome. J Virol 79, 2700-2708. Friebe, P., Bartenschlager, R., 2002. Genetic analysis of sequences in the 3' nontranslated region of hepatitis C virus that are important for RNA replication. J Virol 76, 5326-5338. Gale, M.J., Jr., Korth, M.J., Katze, M.G., 1998. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance. Clin Diagn Virol 10, 157-162. Gonzalez, M.E., Carrasco, L., 2003. Viroporins. FEBS Lett 552, 28-34. Grakoui, A., McCourt, D.W., Wychowski, C., Feinstone, S.M., Rice, C.M., 1993a. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol 67, 2832-2843. Grakoui, A., McCourt, D.W., Wychowski, C., Feinstone, S.M., Rice, C.M., 1993b. A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci U S A 90, 10583-10587. Grakoui, A., Wychowski, C., Lin, C., Feinstone, S.M., Rice, C.M., 1993c. Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67, 1385-1395. Gretton, S.N., Taylor, A.I., McLauchlan, J., 2005. Mobility of the hepatitis C virus NS4B protein on the endoplasmic reticulum membrane and membrane-associated foci. J Gen Virol 86, 1415-1421. Han, J.H., Shyamala, V., Richman, K.H., Brauer, M.J., Irvine, B., Urdea, M.S., Tekamp-Olson, P., Kuo, G., Choo, Q.L., Houghton, M., 1991. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end. Proc Natl Acad Sci U S A 88, 1711-1715. Hawley-Nelson, P., Roop, D.R., Cheng, C.K., Krieg, T.M., Yuspa, S.H., 1988. Molecular cloning of mouse epidermal cystatin A and detection of regulated expression in differentiation and tumorigenesis. Mol Carcinog 1, 202-211. Hijikata, M., Mizushima, H., Akagi, T., Mori, S., Kakiuchi, N., Kato, N., Tanaka, T., Kimura, K., Shimotohno, K., 1993. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol 67, 4665-4675. Ito, M., Kusunoki, H., Mizuochi, T., 2011. Peripheral B cells as reservoirs for persistent HCV infection. Front Microbiol 2, 177. Jacobson, I.M., McHutchison, J.G., Dusheiko, G., Di Bisceglie, A.M., Reddy, K.R., Bzowej, N.H., Marcellin, P., Muir, A.J., Ferenci, P., Flisiak, R., George, J., Rizzetto, M., Shouval, D., Sola, R., Terg, R.A., Yoshida, E.M., Adda, N., Bengtsson, L., Sankoh, A.J., Kieffer, T.L., George, S., Kauffman, R.S., Zeuzem, S., Team, A.S., 2011. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 364, 2405-2416. Kan, Y., Okabayashi, T., Yokota, S., Yamamoto, S., Fujii, N., Yamashita, T., 2012. Imiquimod suppresses propagation of herpes simplex virus 1 by upregulation of cystatin A via the adenosine receptor A1 pathway. J Virol 86, 10338-10346. Kou, Y.H., Chang, M.F., Wang, Y.M., Hung, T.M., Chang, S.C., 2007. Differential requirements of NS4A for internal NS3 cleavage and polyprotein processing of hepatitis C virus. J Virol 81, 7999-8008. Kuopio, T., Kankaanranta, A., Jalava, P., Kronqvist, P., Kotkansalo, T., Weber, E., Collan, Y., 1998. Cysteine proteinase inhibitor cystatin A in breast cancer. Cancer Res 58, 432-436. Lah, T.T., Clifford, J.L., Helmer, K.M., Day, N.A., Moin, K., Honn, K.V., Crissman, J.D., Sloane, B.F., 1989. Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochim Biophys Acta 993, 63-73. Liu, Q., Bhat, R.A., Prince, A.M., Zhang, P., 1999. The hepatitis C virus NS2 protein generated by NS2-3 autocleavage is required for NS5A phosphorylation. Biochem Biophys Res Commun 254, 572-577. Madan, V., Paul, D., Lohmann, V., Bartenschlager, R., 2014. Inhibition of HCV replication by cyclophilin antagonists is linked to replication fitness and occurs by inhibition of membranous web formation. Gastroenterology 146, 1361-1372 e1369. Najda-Bernatowicz, A., Krawczyk, M., Stankiewicz-Drogon, A., Bretner, M., Boguszewska-Chachulska, A.M., 2010. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication. Bioorg Med Chem 18, 5129-5136. Niederau, C., Lange, S., Heintges, T., Erhardt, A., Buschkamp, M., Hurter, D., Nawrocki, M., Kruska, L., Hensel, F., Petry, W., Haussinger, D., 1998. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 28, 1687-1695. Pallaoro, M., Lahm, A., Biasiol, G., Brunetti, M., Nardella, C., Orsatti, L., Bonelli, F., Orru, S., Narjes, F., Steinkuhler, C., 2001. Characterization of the hepatitis C virus NS2/3 processing reaction by using a purified precursor protein. J Virol 75, 9939-9946. Pavlova, A., Bjork, I., 2002. The role of the second binding loop of the cysteine protease inhibitor, cystatin A (stefin A), in stabilizing complexes with target proteases is exerted predominantly by Leu73. Eur J Biochem 269, 5649-5658. Pawlotsky, J.M., 2003. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res 59, 1-11. Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A.J., Houghton, M., Rosa, D., Grandi, G., Abrignani, S., 1998. Binding of hepatitis C virus to CD81. Science 282, 938-941. Poordad, F., McCone, J., Jr., Bacon, B.R., Bruno, S., Manns, M.P., Sulkowski, M.S., Jacobson, I.M., Reddy, K.R., Goodman, Z.D., Boparai, N., DiNubile, M.J., Sniukiene, V., Brass, C.A., Albrecht, J.K., Bronowicki, J.P., Investigators, S.-. 2011. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 364, 1195-1206. Reed, K.E., Grakoui, A., Rice, C.M., 1995. Hepatitis C virus-encoded NS2-3 protease: cleavage-site mutagenesis and requirements for bimolecular cleavage. J Virol 69, 4127-4136. Saitoh, E., Isemura, S., Sanada, K., Ohnishi, K., 1991. Cystatins of family II are harboring two domains which retain inhibitory activities against the proteinases. Biochem Biophys Res Commun 175, 1070-1075. Sakai, A., Claire, M.S., Faulk, K., Govindarajan, S., Emerson, S.U., Purcell, R.H., Bukh, J., 2003. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc Natl Acad Sci U S A 100, 11646-11651. Sakamuro, D., Furukawa, T., Takegami, T., 1995. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 69, 3893-3896. Schwer, B., Ren, S., Pietschmann, T., Kartenbeck, J., Kaehlcke, K., Bartenschlager, R., Yen, T.S., Ott, M., 2004. Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J Virol 78, 7958-7968. Simmonds, P., 2004. Genetic diversity and evolution of hepatitis C virus--15 years on. J Gen Virol 85, 3173-3188. Smith, D.B., Bukh, J., Kuiken, C., Muerhoff, A.S., Rice, C.M., Stapleton, J.T., Simmonds, P., 2014. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource. Hepatology 59, 318-327. Stempniak, M., Hostomska, Z., Nodes, B.R., Hostomsky, Z., 1997. The NS3 proteinase domain of hepatitis C virus is a zinc-containing enzyme. J Virol 71, 2881-2886. Tai, C.L., Chi, W.K., Chen, D.S., Hwang, L.H., 1996. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J Virol 70, 8477-8484. Tanji, Y., Hijikata, M., Hirowatari, Y., Shimotohno, K., 1994. Hepatitis C virus polyprotein processing: kinetics and mutagenic analysis of serine proteinase-dependent cleavage. J Virol 68, 8418-8422. Tsubouchi, E., Akbar, S.M., Horiike, N., Onji, M., 2004. Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection. J Gastroenterol 39, 754-762. Turk, V., Brzin, J., Lenarcic, B., Locnikar, P., Popovic, T., Ritonja, A., Babnik, J., Bode, W., Machleidt, W., 1985. Structure and function of lysosomal cysteine proteinases and their protein inhibitors. Prog Clin Biol Res 180, 91-103. Watashi, K., Ishii, N., Hijikata, M., Inoue, D., Murata, T., Miyanari, Y., Shimotohno, K., 2005. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol Cell 19, 111-122. Welbourn, S., Pause, A., 2007. The hepatitis C virus NS2/3 protease. Curr Issues Mol Biol 9, 63-69. Yamaga, A.K., Ou, J.H., 2002. Membrane topology of the hepatitis C virus NS2 protein. J Biol Chem 277, 33228-33234. Zemel, R., Gerechet, S., Greif, H., Bachmatove, L., Birk, Y., Golan-Goldhirsh, A., Kunin, M., Berdichevsky, Y., Benhar, I., Tur-Kaspa, R., 2001. Cell transformation induced by hepatitis C virus NS3 serine protease. J Viral Hepat 8, 96-102. 高智賢, 2008. 利用新建立之C型肝炎病毒感染細胞株篩選可調節病毒複製之宿主細胞因子及化合物. 國立臺灣大學. 蘇堉嘉, 2013. Cystatin-A與C型肝炎病毒非結構性蛋白質NS3之功能性結合作用. 國立臺灣大學. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58237 | - |
| dc.description.abstract | C型肝炎病毒具有兩個蛋白酶，NS2/3半胱胺酸蛋白酶(cysteine protease)及NS3絲胺酸蛋白酶(serine protease)。兩者共同參與病毒多蛋白質前驅物的切割，以產生具功能性的非結構性蛋白質，協助病毒RNA複製。我們實驗室先前研究也發現基因型1b之病毒NS3蛋白質在輔助因子NS4A存在下可在第369、402與462的胺基酸位點進行自我內部截切，截切產物NS3(1-402)較NS3全長具有更高的細胞轉型能力。當利用親和性管柱分析與NS3(1-402)會形成複合物的細胞因子時，發現Huh7細胞中的cystatin-A可與NS3(1-402)被共同純化出來，表示兩者間可能具有交互作用。Cystatin-A為一半胱胺酸蛋白酶抑制蛋白(cysteine protease inhibitor)，可調控細胞中半胱胺酸蛋白酶的活性，參與表皮的發育及維護。當細胞中cystatin-A的表現量下降時，可能造成半胱胺酸蛋白酶活性不受調控而導致細胞癌變。本研究在探討cystatin-A半胱胺酸蛋白酶抑制蛋白與NS3(1-402)被共同純化出來的生物意義，以及此蛋白酶抑制蛋白是否會抑制NS2/3的自我切割能力。結果發現在293T細胞中，cystatin-A雖會與NS3全長有交互作用，但對NS3的表現量和蛋白酶活性並無顯著影響，cystatin-A也不會抑制NS2/3的蛋白酶切割活性。進一步以即時定量聚合酶連鎖反應探討cystatin-A是否影響病毒之複製，結果顯示cystatin-A蛋白質的表現，會減少病毒基因體RNA的複製，其調節機制有待進一步探討。 | zh_TW |
| dc.description.abstract | Hepatitis C virus (HCV) possesses two viral proteases, NS2/3 cysteine protease and NS3 serine protease, which participate in the viral polyprotein processing to generate functional non-structural proteins. In addition to polyprotein processing, our previous studies also demonstrated an internal NS3 cleavage activity of HCV genotype 1b that occurred at residue 369, 402 and 462 in the presence of NS4A. The internal cleavage product, NS3(1-402), had a higher transforming activity than the full-length NS3. By performing tandem affinity purification, cystatin-A was co-purified with NS3(1-402) protein, implying an association of the two proteins. Cystatin-A, as a cysteine protease inhibitor, can modulate cellular cysteine protease activity and plays roles in epidermal development and maintainance. The down-regulation of cystatin-A was suggested to be involved in tumorigenesis, including cancers of breast, pancrea, brain, and lung. In this study, biological significances for the association between cystatin-A and NS3(1-402) were examined. Knowing that HCV NS2/3 possesses cysteine protease activity, a potential inhibitory effect of cystatin-A was also examined. The results showed that cystatin-A had no inhibitory effect to the NS2/3 cysteine protease and NS3 serine protease activity. On the other hand, cystatin-A inhibited the RNA replication of HCV JFH-1. Molecular mechanisms involved in the inhibition of HCV RNA replication remain to be elucidated. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-16T08:09:00Z (GMT). No. of bitstreams: 1 ntu-103-R00445127-1.pdf: 2797597 bytes, checksum: 94e59d82649b800d7285321f09b102ab (MD5) Previous issue date: 2014 | en |
| dc.description.tableofcontents | 摘要 2
Abstract 3 目錄 4 緒論 7 壹、C型肝炎病毒 7 貳、非結構性蛋白質NS2的特性 11 參、非結構性蛋白質NS3的特性 12 肆、半胱胺酸蛋白酶抑制蛋白Cystatin 13 研究目的 16 實驗材料 17 實驗方法 24 實驗結果 28 討論 31 圖表 33 附錄 48 參考文獻 50 | |
| dc.language.iso | zh-TW | |
| dc.subject | 非結構性蛋白質2 | zh_TW |
| dc.subject | 半胱胺酸蛋白? | zh_TW |
| dc.subject | 絲胺酸蛋白? | zh_TW |
| dc.subject | 半胱胺酸蛋白?抑制蛋白 | zh_TW |
| dc.subject | C型肝炎病毒 | zh_TW |
| dc.subject | 非結構性蛋白質3 | zh_TW |
| dc.subject | cystatin-A | en |
| dc.subject | cystatin | en |
| dc.subject | serine protease | en |
| dc.subject | cysteine protease | en |
| dc.subject | NS3 | en |
| dc.subject | Hepatitis C virus | en |
| dc.subject | replication | en |
| dc.subject | NS2/3 | en |
| dc.subject | HCV | en |
| dc.title | Cystatin-A與C型肝炎病毒非結構性蛋白質NS3交互作用之探討 | zh_TW |
| dc.title | Studies on the interaction between cystatin-A and the NS3 protein of hepatitis C virus | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 102-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 董馨蓮(Sin-Lien Doong),林素芳(Su-Fang Lin) | |
| dc.subject.keyword | C型肝炎病毒,非結構性蛋白質2,非結構性蛋白質3,半胱胺酸蛋白?,絲胺酸蛋白?,半胱胺酸蛋白?抑制蛋白, | zh_TW |
| dc.subject.keyword | Hepatitis C virus,HCV,NS2/3,NS3,cysteine protease,serine protease,cystatin,cystatin-A,replication, | en |
| dc.relation.page | 55 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2014-05-09 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 微生物學研究所 | zh_TW |
| 顯示於系所單位： | 微生物學科所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-103-1.pdf 未授權公開取用 | 2.73 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。